Consequently, these results indicated that overexpression of SELENOW in multiple myeloma may be associated with excessive osteoclast differentiation via efficient nuclear translocation of the osteoclastogenic transcription factors NF-κB and NFATc1. This evidence concerns the gene NFATC1 and plasma cell myeloma.